Direkt zum Inhalt

Owner only: item control page
Treutwein, Marius ; Hipp, Matthias ; Loeschel, Rainer ; Koelbl, Oliver ; Dobler, Barbara

EP-1615: Second cancer risk after radiation of localized prostate cancer with and without flattening filter

Treutwein, Marius , Hipp, Matthias, Loeschel, Rainer, Koelbl, Oliver and Dobler, Barbara (2017) EP-1615: Second cancer risk after radiation of localized prostate cancer with and without flattening filter. Radiotherapy & Oncology 123 (Supp1), S873.

Date of publication of this fulltext: 11 May 2017 11:29
Article
DOI to cite this document: 10.5283/epub.35405


Abstract

Purpose: Radiotherapy is a standard treatment modality with curative intent for localized prostate cancer. Prostate cancer is a disease of elderly men. Nevertheless these patients have a remaining life span of ten years or more. Radiotherapy compared to surgery may increase the risk for second cancer. Minimizing this risk can be one criterion in deciding for a specific technique. Therefore we ...

Purpose:
Radiotherapy is a standard treatment modality with curative intent for localized prostate cancer. Prostate cancer is a disease of elderly men. Nevertheless these patients have a remaining life span of ten years or more. Radiotherapy compared to surgery may increase the risk for second cancer. Minimizing this risk can be one criterion in deciding for a specific technique. Therefore we compared the organ equivalent dose (OED) and excess absolute risk (EAR) for second cancer for different treatment techniques.
Material and methods:
For ten patients four different plans were calculated, using a seven field intensity modulated radiotherapy (IMRT) and a single arc volumetric modulated arc therapy (VMAT) with and without flattening filter. The optimization was performed as simultaneous integrated boost in 33 fractions, aiming for 59.4 Gy minimum dose to the PTV and 71.0 Gy minimum dose and 74.2 Gy maximum dose to the CTV. The OED was computed for the urinary bladder and the rectum from dose volume histograms for the linear-exponential and the plateau dose-response model. The EAR can be derived from the OED, taking age modifying parameters into account. The statistical analysis was performed using the Wilcoxon test in IBM® SPSS® Statistics 23 (IBM Corporation).
Results:
Within one technique (IMRT or VMAT) the average value of the OED is lower for the flattening filter free (FFF) mode compared to flat beams (FB) in both organs and for both dose-response models with one exception: In the urinary bladder it is the other way round for IMRT and the linear-exponential model. These results are statistically significant (level of significance 5%). The results for VMAT are statistically significant for the rectum only in both models.
Comparing IMRT and VMAT the results are ambiguous: For the linear-exponential model the OED is lower with IMRT for both FB and FFF, for the plateau model lower OEDs are achieved with VMAT. All results are significant, except of one (lin-exp. model, FFF, urinary bladder, p = 7.4%).
Conclusion:
Some statistically significant differences have been found for the different treatment techniques and modes. However, they depend on the dose-response model. For the plateau model the lowest EAR is found for VMAT FFF in both organs at risk, for the linear-exponential model IMRT FB shows the minimum values. Plan quality and efficiency should additionally be regarded before the decision for a specific technique and mode.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleRadiotherapy & Oncology
Publisher:Elsevier
Volume:123
Number of Issue or Book Chapter:Supp1
Page Range:S873
Date5 May 2017
Additional Information (public)Presentation at the ESTRO36 congress of the European SocieTy for Radiotherapy & Oncology at Vienna. This work was supported by the Bavarian State Ministry of the Environment and Consumer Protection (Bayerisches Ministerium für Umwelt und Verbraucherschutz). The first DOI refers to the publisher. The second DOI refers to the complete gallery of all posters of the congress ESTRO36
InstitutionsMedicine > Lehrstuhl für Strahlentherapie
Identification Number
ValueType
http://dx.doi.org/10.1016/S0167-8140(17)32050-9DOI
10.3252/pso.eu.ESTRO36.2017DOI
KeywordsSecond cancer risk, prostate cancer, FFF, flattening filter free, IMRT, VMAT
Dewey Decimal Classification500 Science > 530 Physics
600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID35405

Export bibliographical data

Owner only: item control page

nach oben